Colgate-Palmolive: SWAN Stock, But Valuation Is A Concern
Colgate-Palmolive (CL) is a company that I've wanted to add to my portfolio for several years; however, it's one that has always eluded my grasp. Much of that stems from its chronic premium valuation that is well deserved based on the stability of the business. In hindsight, I should have added shares when I updated my valuation on the business in January last year with shares producing a total return over 27% in that time. While hindsight is 20/20, I still believe that the limited growth prospects warrant caution before adding shares of this otherwise great company. With a year passing since I last examined Colgate-Palmolive, it was time to update my valuation to see if now might be the time to finally add this business to my holdings.